| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIC.201100120 |
| P698 | PubMed publication ID | 21538763 |
| P50 | author | Roderich D. Süssmuth | Q41669426 |
| Tanja Schneider | Q42890232 | ||
| P2093 | author name string | Saskia Rausch | |
| Anne Hänchen | |||
| Alexander Denisiuk | |||
| Marius Löhken | |||
| P2860 | cites work | Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation | Q28368368 |
| 3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria | Q34352165 | ||
| Glycopeptide and lipoglycopeptide antibiotics | Q34392366 | ||
| An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway | Q37652425 | ||
| Total synthesis of the antiviral peptide antibiotic feglymycin | Q39889462 | ||
| Kinetic and crystallographic studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase | Q42845111 | ||
| Inhibitors of the bacterial cell wall biosynthesis enzyme MurC. | Q43621566 | ||
| Characterization and inhibition study of MurA enzyme by capillary electrophoresis | Q43871900 | ||
| Purification, crystallization and preliminary X-ray analysis of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC). | Q44522560 | ||
| Antibacterial discovery and development--the failure of success? | Q47825932 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1171-1173 | |
| P577 | publication date | 2011-04-28 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. | |
| P478 | volume | 12 |
| Q108127361 | A Machine Learning Bioinformatics Method to Predict Biological Activity from Biosynthetic Gene Clusters |
| Q37112508 | Advances in MRSA drug discovery: where are we and where do we need to be? |
| Q46453851 | Alanine scan of the peptide antibiotic feglymycin: assessment of amino acid side chains contributing to antimicrobial activity |
| Q52861046 | Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism. |
| Q37335513 | Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis |
| Q36518393 | Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway |
| Q41826662 | Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation. |
| Q35223217 | UDP-N-acetylmuramic acid l-alanine ligase (MurC) inhibition in a tolC mutant Escherichia coli strain leads to cell death |
Search more.